Cas No.: | 1156-19-0 |
Synonyms: | Tolazamide;NSC 70762 |
SMILES: | CC1=CC=C(S(NC(NN2CCCCCC2)=O)(=O)=O)C=C1 |
Formula: | C14H21N3O3S |
M.Wt: | 311.4 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Tolazamide is a first generation sulfonylurea that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (KIR6.2; IC50 = 4.2 µM in HEK293 cells transfected with the human receptor).It has no effect on glucose uptake in L6 rat skeletal muscle cells when used at a concentration of 0.6 mg/mL but enhances glucose uptake two-fold when used in combination with insulin.In vivo, tolazamide (128 mg/kg) reduces glomerulosclerosis and albumin excretion in a rat model of insulin-dependent diabetes induced by streptozotocin.Formulations containing tolazamide have been used in the treatment of type 2 diabetes. |